Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Public ClinicalTrials.gov record NCT00969709. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER fixed doses versus placebo in the treatment of outpatients with major depressive disorder.
Study identification
- NCT ID
- NCT00969709
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 724 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2009 (Type not available)
- Primary completion
- May 2011 (Actual)
- Completion
- Not listed
- Last update posted
- Oct 25, 2013
Started 2009
United States locations
- U.S. sites
- 38
- U.S. states
- 18
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site | Phoenix | Arizona | 85020 | — |
| Forest Investigative Site | Scottsdale | Arizona | 85254 | — |
| Forest Investigative Site | Beverly Hills | California | 90210 | — |
| Forest Investigative Site | Costa Mesa | California | 92626 | — |
| Forest Investigative Site | Escondido | California | 92025 | — |
| Forest Investigative Site | Oceanside | California | 92056 | — |
| Forest Investigative Site | Sherman Oaks | California | 91403 | — |
| Forest Investigative Site | Denver | Colorado | 80239 | — |
| Forest Investigative Site | Cromwell | Connecticut | 06416 | — |
| Forest Investigative Site | Coral Springs | Florida | 33067 | — |
| Forest Investigative Site | Fort Myers | Florida | 33912 | — |
| Forest Investigative Site | Hallandale | Florida | 33009 | — |
| Forest Investigative Site | Jacksonville | Florida | 32216 | — |
| Forest Investigative Site | Orlando | Florida | 32806 | — |
| Forest Investigative Site | West Palm Beach | Florida | 33407 | — |
| Forest Investigative Site | Hoffman Estates | Illinois | 60169 | — |
| Forest Investigative Site | Wichita | Kansas | 67206 | — |
| Forest Investigative Site | Baltimore | Maryland | 21285 | — |
| Forest Investigative Site | Rockville | Maryland | 20852 | — |
| Forest Investigative Site | Cherry Hill | New Jersey | 08002 | — |
| Forest Investigative Site | Willingboro | New Jersey | 08046 | — |
| Forest Investigative Site | Brooklyn | New York | 11235 | — |
| Forest Investigative Site | Mount Kisco | New York | 10549 | — |
| Forest Investigative Site | New York | New York | 10003 | — |
| Forest Investigative Site | New York | New York | 10021 | — |
| Forest Investigative Site | Staten Island | New York | 10312 | — |
| Forest Investigative Site | Raleigh | North Carolina | 27607 | — |
| Forest Investigative Site | Canton | Ohio | 44718 | — |
| Forest Investigative Site | Portland | Oregon | 97210 | — |
| Forest Investigative Site | Media | Pennsylvania | 19063 | — |
| Forest Investigative Site | Norristown | Pennsylvania | 19403 | — |
| Forest Investigative Site | Lincoln | Rhode Island | 02865 | — |
| Forest Investigative Site | Memphis | Tennessee | 38119 | — |
| Forest Investigative Site | Dallas | Texas | 75230 | — |
| Forest Investigative Site | Dallas | Texas | 75231 | — |
| Forest Investigative Site | San Antonio | Texas | 78229 | — |
| Forest Investigative Site | Bellevue | Washington | 98007 | — |
| Forest Investigative Site | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00969709, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2013 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00969709 live on ClinicalTrials.gov.